SLC5A5 and glioblastoma: But, maintaining an ideal drug delivery and therapeutic effect using radionuclides in humans, and not only targeting NIS-expressing GBM cells but also the surrounding cells in the GBM microenvironment, needs to be targetable with imaging or treatment [81].